In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.

Cefodizime (HR221) is a new alpha-methoxyimino cephalosporin developed by Hoechst-Roussel with a reported serum half-life of over 2 h. In vitro susceptibility studies showed that the cefodizime spectrum includes all those Enterobacteriaceae, staphylococci, Streptococcus spp., Haemophilus spp., and N...

Volledige beschrijving

Bibliografische gegevens

Gepubliceerd in:	Antimicrob Agents Chemother
Hoofdauteurs:	Jones, R N, Barry, A L, Thornsberry, C, Wilson, H W
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	American Society for Microbiology (ASM) 1981
Onderwerpen:	Research Article
Online toegang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181795/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6275785/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.20.6.760
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!